Association of Plasminogen Activator Inhibitor 1 (PAI-1) 4G/5G Polymorphism and Susceptibility to SLE in Egyptian Children and Adolescents: A Multicenter Study [Corrigendum]

Yousef AA, Mohamed FY, Boraey NF, et al. J Inflamm Res. 2020;13:1103— 1111. The authors have advised the affiliation list on page 1103is incorrect. The correct author list and affiliations are asfollows: Aly A Yousef, 1 Faisal Y Mohamed, 2 Naglaa F Boraey, 3Nagwa E Akeel, 4 Attia...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Yousef AA, Mohamed FY, Boraey NF, Akeel NE, Soliman AA, Waked NM, Hashem MIA, Shehata H, Fahmy DS, Ismael A, Ibrahim LM, Ibrahim MAM, Salem HF, Yousry SM, Osman SF, Fouad RA, Enan ET, Attia MA, Afify MR, Zeidan NMS, Nashat M
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	plasminogen activator inhibitor-1 (pai-1) gene polymorphism sle children adolescents Pathology RB1-214 Therapeutics. Pharmacology RM1-950
Acceso en línea:	https://doaj.org/article/99db3fce92fe4ca6878a6ba8539a2f8c
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:99db3fce92fe4ca6878a6ba8539a2f8c
record_format	dspace
spelling	oai:doaj.org-article:99db3fce92fe4ca6878a6ba8539a2f8c2021-12-02T14:24:09ZAssociation of Plasminogen Activator Inhibitor 1 (PAI-1) 4G/5G Polymorphism and Susceptibility to SLE in Egyptian Children and Adolescents: A Multicenter Study [Corrigendum]1178-7031https://doaj.org/article/99db3fce92fe4ca6878a6ba8539a2f8c2021-02-01T00:00:00Zhttps://www.dovepress.com/corrigendum-association-of-plasminogen-activator-inhibitor-1-pai-1-4g5-peer-reviewed-article-JIRhttps://doaj.org/toc/1178-7031Yousef AA, Mohamed FY, Boraey NF, et al. J Inflamm Res. 2020;13:1103— 1111. The authors have advised the affiliation list on page 1103is incorrect. The correct author list and affiliations are asfollows: Aly A Yousef, 1 Faisal Y Mohamed, 2 Naglaa F Boraey, 3Nagwa E Akeel, 4 Attia A Soliman, 4 Nevin M Waked, 5Mustafa IA Hashem, 4 Hassan Shehata, 4 Dalia S Fahmy, 6Ali Ismael, 7 Lamya M Ibrahim, 8 Mohamed AM Ibrahim, 9Hanan F Salem, 10 Sherif M Yousry, 11 Sherif F Osman, 12Rania A Fouad, 13,14 Eman T Enan, 15 MohammedA Attia, 16,17 Mona R Afify, 18 Nancy MS Zeidan, 19Mohamed Nashat 20 Read the original article Yousef AAMohamed FYBoraey NFAkeel NESoliman AAWaked NMHashem MIAShehata HFahmy DSIsmael AIbrahim LMIbrahim MAMSalem HFYousry SMOsman SFFouad RAEnan ETAttia MAAfify MRZeidan NMSNashat MDove Medical Pressarticleplasminogen activator inhibitor-1 (pai-1)gene polymorphismslechildrenadolescentsPathologyRB1-214Therapeutics. PharmacologyRM1-950ENJournal of Inflammation Research, Vol Volume 14, Pp 265-266 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	plasminogen activator inhibitor-1 (pai-1) gene polymorphism sle children adolescents Pathology RB1-214 Therapeutics. Pharmacology RM1-950
spellingShingle	plasminogen activator inhibitor-1 (pai-1) gene polymorphism sle children adolescents Pathology RB1-214 Therapeutics. Pharmacology RM1-950 Yousef AA Mohamed FY Boraey NF Akeel NE Soliman AA Waked NM Hashem MIA Shehata H Fahmy DS Ismael A Ibrahim LM Ibrahim MAM Salem HF Yousry SM Osman SF Fouad RA Enan ET Attia MA Afify MR Zeidan NMS Nashat M Association of Plasminogen Activator Inhibitor 1 (PAI-1) 4G/5G Polymorphism and Susceptibility to SLE in Egyptian Children and Adolescents: A Multicenter Study [Corrigendum]
description	Yousef AA, Mohamed FY, Boraey NF, et al. J Inflamm Res. 2020;13:1103— 1111. The authors have advised the affiliation list on page 1103is incorrect. The correct author list and affiliations are asfollows: Aly A Yousef, 1 Faisal Y Mohamed, 2 Naglaa F Boraey, 3Nagwa E Akeel, 4 Attia A Soliman, 4 Nevin M Waked, 5Mustafa IA Hashem, 4 Hassan Shehata, 4 Dalia S Fahmy, 6Ali Ismael, 7 Lamya M Ibrahim, 8 Mohamed AM Ibrahim, 9Hanan F Salem, 10 Sherif M Yousry, 11 Sherif F Osman, 12Rania A Fouad, 13,14 Eman T Enan, 15 MohammedA Attia, 16,17 Mona R Afify, 18 Nancy MS Zeidan, 19Mohamed Nashat 20 Read the original article
format	article
author	Yousef AA Mohamed FY Boraey NF Akeel NE Soliman AA Waked NM Hashem MIA Shehata H Fahmy DS Ismael A Ibrahim LM Ibrahim MAM Salem HF Yousry SM Osman SF Fouad RA Enan ET Attia MA Afify MR Zeidan NMS Nashat M
author_facet	Yousef AA Mohamed FY Boraey NF Akeel NE Soliman AA Waked NM Hashem MIA Shehata H Fahmy DS Ismael A Ibrahim LM Ibrahim MAM Salem HF Yousry SM Osman SF Fouad RA Enan ET Attia MA Afify MR Zeidan NMS Nashat M
author_sort	Yousef AA
title	Association of Plasminogen Activator Inhibitor 1 (PAI-1) 4G/5G Polymorphism and Susceptibility to SLE in Egyptian Children and Adolescents: A Multicenter Study [Corrigendum]
title_short	Association of Plasminogen Activator Inhibitor 1 (PAI-1) 4G/5G Polymorphism and Susceptibility to SLE in Egyptian Children and Adolescents: A Multicenter Study [Corrigendum]
title_full	Association of Plasminogen Activator Inhibitor 1 (PAI-1) 4G/5G Polymorphism and Susceptibility to SLE in Egyptian Children and Adolescents: A Multicenter Study [Corrigendum]
title_fullStr	Association of Plasminogen Activator Inhibitor 1 (PAI-1) 4G/5G Polymorphism and Susceptibility to SLE in Egyptian Children and Adolescents: A Multicenter Study [Corrigendum]
title_full_unstemmed	Association of Plasminogen Activator Inhibitor 1 (PAI-1) 4G/5G Polymorphism and Susceptibility to SLE in Egyptian Children and Adolescents: A Multicenter Study [Corrigendum]
title_sort	association of plasminogen activator inhibitor 1 (pai-1) 4g/5g polymorphism and susceptibility to sle in egyptian children and adolescents: a multicenter study [corrigendum]
publisher	Dove Medical Press
publishDate	2021
url	https://doaj.org/article/99db3fce92fe4ca6878a6ba8539a2f8c
work_keys_str_mv	AT yousefaa associationofplasminogenactivatorinhibitor1pai14g5gpolymorphismandsusceptibilitytosleinegyptianchildrenandadolescentsamulticenterstudycorrigendum AT mohamedfy associationofplasminogenactivatorinhibitor1pai14g5gpolymorphismandsusceptibilitytosleinegyptianchildrenandadolescentsamulticenterstudycorrigendum AT boraeynf associationofplasminogenactivatorinhibitor1pai14g5gpolymorphismandsusceptibilitytosleinegyptianchildrenandadolescentsamulticenterstudycorrigendum AT akeelne associationofplasminogenactivatorinhibitor1pai14g5gpolymorphismandsusceptibilitytosleinegyptianchildrenandadolescentsamulticenterstudycorrigendum AT solimanaa associationofplasminogenactivatorinhibitor1pai14g5gpolymorphismandsusceptibilitytosleinegyptianchildrenandadolescentsamulticenterstudycorrigendum AT wakednm associationofplasminogenactivatorinhibitor1pai14g5gpolymorphismandsusceptibilitytosleinegyptianchildrenandadolescentsamulticenterstudycorrigendum AT hashemmia associationofplasminogenactivatorinhibitor1pai14g5gpolymorphismandsusceptibilitytosleinegyptianchildrenandadolescentsamulticenterstudycorrigendum AT shehatah associationofplasminogenactivatorinhibitor1pai14g5gpolymorphismandsusceptibilitytosleinegyptianchildrenandadolescentsamulticenterstudycorrigendum AT fahmyds associationofplasminogenactivatorinhibitor1pai14g5gpolymorphismandsusceptibilitytosleinegyptianchildrenandadolescentsamulticenterstudycorrigendum AT ismaela associationofplasminogenactivatorinhibitor1pai14g5gpolymorphismandsusceptibilitytosleinegyptianchildrenandadolescentsamulticenterstudycorrigendum AT ibrahimlm associationofplasminogenactivatorinhibitor1pai14g5gpolymorphismandsusceptibilitytosleinegyptianchildrenandadolescentsamulticenterstudycorrigendum AT ibrahimmam associationofplasminogenactivatorinhibitor1pai14g5gpolymorphismandsusceptibilitytosleinegyptianchildrenandadolescentsamulticenterstudycorrigendum AT salemhf associationofplasminogenactivatorinhibitor1pai14g5gpolymorphismandsusceptibilitytosleinegyptianchildrenandadolescentsamulticenterstudycorrigendum AT yousrysm associationofplasminogenactivatorinhibitor1pai14g5gpolymorphismandsusceptibilitytosleinegyptianchildrenandadolescentsamulticenterstudycorrigendum AT osmansf associationofplasminogenactivatorinhibitor1pai14g5gpolymorphismandsusceptibilitytosleinegyptianchildrenandadolescentsamulticenterstudycorrigendum AT fouadra associationofplasminogenactivatorinhibitor1pai14g5gpolymorphismandsusceptibilitytosleinegyptianchildrenandadolescentsamulticenterstudycorrigendum AT enanet associationofplasminogenactivatorinhibitor1pai14g5gpolymorphismandsusceptibilitytosleinegyptianchildrenandadolescentsamulticenterstudycorrigendum AT attiama associationofplasminogenactivatorinhibitor1pai14g5gpolymorphismandsusceptibilitytosleinegyptianchildrenandadolescentsamulticenterstudycorrigendum AT afifymr associationofplasminogenactivatorinhibitor1pai14g5gpolymorphismandsusceptibilitytosleinegyptianchildrenandadolescentsamulticenterstudycorrigendum AT zeidannms associationofplasminogenactivatorinhibitor1pai14g5gpolymorphismandsusceptibilitytosleinegyptianchildrenandadolescentsamulticenterstudycorrigendum AT nashatm associationofplasminogenactivatorinhibitor1pai14g5gpolymorphismandsusceptibilitytosleinegyptianchildrenandadolescentsamulticenterstudycorrigendum
_version_	1718391440704274432

Association of Plasminogen Activator Inhibitor 1 (PAI-1) 4G/5G Polymorphism and Susceptibility to SLE in Egyptian Children and Adolescents: A Multicenter Study [Corrigendum]

Ejemplares similares